City of Hope Elects Award-Winning Visionary to Board of Directors

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190516005091/en/

Phil Fasano (Photo: Business Wire)

“Phil Fasano has an impressive track record in enterprise digital strategies and technology innovation,” said Robert W. Stone, president and CEO of City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases. “He shares our commitment to using leading-edge information technology to advance scientific innovation and deliver personalized medicine to patients.”

Fasano, CEO of strategic advisory and consulting firm Bay Advisors LLC, brings more than two decades of experience in the financial services, technology, insurance and health care industries. He is an influential voice in the push to evolve how companies create, market and use technologies. His advisory and board relationships include Zenefits, Onclave Networks, Innovaccer, Domo, Open Data Group, Virtual Rehab, NeoEyed, Emirates Airlines and Genpact.

Prior to founding his consultant firm, Fasano was the first global chief information officer and executive vice president at the Fortune 100 global insurance company American International Group (AIG), where he guided technology strategy, capabilities and operations for more than 60,000 employees in 120 countries. Fasano has also been the CIO and executive vice president of Kaiser Permanente, where he implemented electronic medical record systems, activated digital mobile applications and transformed the organization into a digital health care delivery system.

Fasano has a master of business administration from Long Island University and a bachelor’s degree in computer science from the New York Institute of Technology, where he now serves on the board of trustees.

About City of Hope

City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked one of America’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190516005091/en/